Using a person's own immune system to fight cancer: Phase I clinical trial of new immunotherapy beginning
Thursday, April 10, 2014 - 11:02
in Health & Medicine
Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person’s own immune system to fight cancer. It has several advantages over standard cancer therapies, including fewer side effects and an overall better tolerability. It tends to be most effective in patients who have smaller, localized tumors that have not spread to distant sites.